PREPARATION AND IN-VITRO EVALUATION OF MICROBALLOON DRUG DELIVERY SYSTEM OF TELMISARTAN

Authors

  • V. Ganesan Department of Pharmaceutics, The Erode College of Pharmacy, Perundurai Main Road, Vallipurathanpalayam (PO), Veppampalayam, Erode-638 112, Tamil Nadu, India
  • V. S.V.S.P. Krishna Kanth Department of Pharmaceutics, The Erode College of Pharmacy, Perundurai Main Road, Vallipurathanpalayam (PO), Veppampalayam, Erode-638 112, Tamil Nadu, India

Abstract

In present study an attempt was made to prepare hollow microspheres (microballoons) of Telmisartan by emulsion solvent diffusion technique for sustained delivery by using polymers like Hydroxy Propyl Methyl Cellulose (HPMC) and Eudragit RS 100 in order to extend the drug release for about 12 h in the upper GIT, which may result in enhanced absorption and there by improved bioavailability. The particle size was determined by optical micrometer and average particle size was found to be in range of189.5± 2.63 to 124.33± 2.14. Formulation F7 containing HPMC and Eudragit polymer blend showed the best floating ability (91.26%) as compared with other formulations. From Scanning Electron Microscopy (SEM) it was observed that, microballoons were found to be spherical in shape with smooth surface texture with a hollow space within. Among all formulations, F7 showed appropriate balance between buoyancy and drug release rate of 98.32% in 12 h, which is considered as the best formulation.

Keywords:

Telmisartan, Microballoons, Emulsion solvent diffusion technique, Buoyancy, Bioavailability

DOI

https://doi.org/10.25004/IJPSDR.2013.050402

References

1. Yousef Javadzadeh and Sanaz Hamedeyazdan. Novel drug delivery systems for modulation of gastrointestinal transit time. 2013; pp. 393–418.
2. Patel DM, Patel MJ, Patel CN. Multi Particulate System: A Novel Approach in Gastro Retentive Drug Delivery. Int. J. Adv. Pharm. Res. 2011; 2(4): 96-106.
3. Joshi VK, Jaimini M. Microballoons for drug delivery: Review. Asian J. Pharm. Res. Dev 2013; 1 (1): 07-17.
4. Sujata D. Bansode, Veena S. Kasture, Sarita S. Pawar, Sanjay B. Kasture. Formulation and evaluation of telmisartan microspheres by emulsion solvent evaporation technique. J. Appl. Pharm. Sci. 2012; 2 (10): 113-116.
5. Kendre PN, Chaudhari PD. Formulation and evaluation of telmisartan microspheres by solvent evaporation technique. Indo American J. Pharm. Res. 2012:1(41): 651-658.
6. Sato Y, Kawashima Y, Takeuchi H, Yamamoto H. In-vitro evaluation of floating and drug releasing behaviours of hollow microspheres (microballoons) prepared by the emulsion solvent diffusion method. Eur. J. Bio pharm. 2004; 57 (2): 235- 243.
7. Tripathi M, Radhika PR, Siva kumar T. Formulation and evaluation of Glipizide microballoons for floating drug delivery. Bull. Pharm. Res 2011; 1(1):67-74.
8. Gupta NV, Satish CS, ShivaKumar HG. Preparation and characterisation of gelatin-poly (methacrylic acid) interpenetrating polymeric network hydrogels as a pH sensitive system for glipizide. Indian J. Pharm.sci. 2007; 69 (1): 64-68.
9. Manavalen R, Ramasamy C. Physical Pharmaceutics, 2nd Edn, Vignesh Publisher: Tamil Nadu, 2004; pp.456-459
10. Sharma AK, Keservani RK, Dadarwal SC, Choudhary YL, Ramteke S. Formulation and in-vitro characterization of cefpodoxime proxetil gastro-retentive microballoons. Daru 2011; 19 (1) 33-40.
11. Jain SK, Awasthi AR, Jain NK. Calcium silicate based microspheres of repaglinide for gastro retentive floating drug delivery: Preparation and in vitro characterization. J. Control .Release 2005; 300-309.

Published

01-10-2013
Statistics
Abstract Display: 423
PDF Downloads: 559
Dimension Badge

How to Cite

“PREPARATION AND IN-VITRO EVALUATION OF MICROBALLOON DRUG DELIVERY SYSTEM OF TELMISARTAN”. International Journal of Pharmaceutical Sciences and Drug Research, vol. 5, no. 4, Oct. 2013, pp. 141-5, https://doi.org/10.25004/IJPSDR.2013.050402.

Issue

Section

Research Article

How to Cite

“PREPARATION AND IN-VITRO EVALUATION OF MICROBALLOON DRUG DELIVERY SYSTEM OF TELMISARTAN”. International Journal of Pharmaceutical Sciences and Drug Research, vol. 5, no. 4, Oct. 2013, pp. 141-5, https://doi.org/10.25004/IJPSDR.2013.050402.